Trial intelligence / Profile preview

Liraglutide Effects on ER Stress in Obese T2DM

NCT02344186Phase 4Unknown

Sponsor
Temple University
Start
May 2014
Primary completion
Dec 2022
Modality
Peptides
Countries
1
01

Overview

A Phase 4 trial of liraglutide in type 2 diabetes mellitus (T2DM), sponsored by Temple University. Status: unknown.

02

Drugs

03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on NCT02344186.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02344186.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call